FineMedix Co

FineMedix Co EBIT per Share

The EBIT per Share of FineMedix Co (387570.KQ) as of Nov 2, 2026 is -475.16 KRW. In the previous year, EBIT per Share was -5.38 KRW — a change of 8,739.14% (lower).

EBIT per Share

-475.16KRW

YoY

8,739.14%

Last updated:

EBIT per Share of FineMedix Co is 2025 -475.16 KRW. EBIT per Share of FineMedix Co was 2024 -5.38 KRW. It decreases by 8,739.14% lower compared to the previous year.

The FineMedix Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
94.68 KRW
Jan 1, 2023
160.87 KRW
Jan 1, 2024
-5.38 KRW
Jan 1, 2025
-475.16 KRW
The FineMedix Co EBIT per Share history
YEAREBIT per ShareYoY
-475.16KRW+8,739.14%
-5.38KRW-103.34%
160.87KRW+69.91%
94.68KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

FineMedix Co Stock analysis

What does FineMedix Co do? FineMedix Co Ltd generates revenue through the manufacturing and sales of microinvasive medical devices, including therapeutic and diagnostic endoscopes. The company also offers endoscopic surgery devices such as knives, injectors, baskets, endoscopic clips, and snares for endoscopic submucosal dissection and endoscopic mucosal resection. These products are sold to healthcare providers and medical facilities specializing in minimally invasive procedures. The company's primary focus on endoscopic devices positions it within the medical devices manufacturing sector, targeting hospitals and clinics that require advanced tools for minimally invasive surgeries. FineMedix Co Ltd's product portfolio supports both diagnostic and therapeutic applications in endoscopic procedures, catering to the growing demand for less invasive surgical techniques. As a Korea-based firm, FineMedix Co Ltd serves the domestic market with its specialized medical equipment. The company's offerings are designed to meet the needs of medical professionals performing endoscopic surgeries, ensuring precision and efficiency in procedures such as ESD and EMR. FineMedix Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about FineMedix Co stock

EBIT per Share of FineMedix Co is -475.16 KRW in 2025.

EBIT per Share of FineMedix Co changed from -5.38 KRW to -475.16 KRW, representing a 8,739.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share FineMedix Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — FineMedix Co

All Key Metrics — FineMedix Co